| 1 | 2L polyethylene glycol/ascorbic acid (PEG) | - | - | - | - | 1件: 97 97 💬
|
| 2 | 3L-polyethylene glycol (PEG) | - | - | - | - | 1件: 97 97 💬
|
| 3 | 99MTC-S-hynic certolizumab pegol | 1件: Certolizumab pegol Certolizumab pegol (Certolizumab pegol) | 1件: Certolizumab pegol
Certolizumab pegol
(Certolizumab pegol, Certolizumab pegol) 💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 96 💬
|
| 4 | Anakinra and PEG STNF-R1 | 1件: Anakinra Anakinra | 1件: Anakinra
Anakinra
💬
| 2件: IL1R1 IL1R1, IL1R2 💬
| 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 46 46 💬
|
| 5 | Anti TNF humanized antibody FAB fragment-PEG conjugate | - | - | - | - | 1件: 96 96 💬
|
| 6 | ANTI-TNF humanized antibody FAB fragment - PEG conjugate | - | - | - | - | 1件: 46 46 💬
|
| 7 | ANTI-TNF humanized antibody FAB' fragment - PEG conjugate | - | - | - | - | 1件: 46 46 💬
|
| 8 | Avacincaptad pegol | 1件: Avacincaptad pegol Avacincaptad pegol (Avacincaptad pegol sodium) | 1件: Avacincaptad pegol sodium
Avacincaptad pegol sodium
(Avacincaptad pegol sodium) 💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 301 301 💬
|
| 9 | BI-peglyte | - | - | - | - | 2件: 96 96, 97 💬
|
| 10 | BIIB017 (peginterferon BETA-1A) autoinjector | 1件: Peginterferon beta-1a Peginterferon beta-1a (PEG IFN-beta-1a) | 1件: Peginterferon beta-1a
Peginterferon beta-1a
(Peginterferon beta-1a) 💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 11 | CDP870 FAB'-PEG | - | - | - | - | 1件: 46 46 💬
|
| 12 | Certolizumab pegol | 1件: Certolizumab pegol Certolizumab pegol (Certolizumab pegol) | 1件: Certolizumab pegol
Certolizumab pegol
(Certolizumab pegol, Certolizumab pegol) 💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 7件: 37 37, 46, 49, 96, 107, 226, 271 💬
|
| 13 | Certolizumab pegol (CZP) 200 MG | 1件: Certolizumab pegol Certolizumab pegol (Certolizumab pegol) | 1件: Certolizumab pegol
Certolizumab pegol
(Certolizumab pegol, Certolizumab pegol) 💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 14 | Certolizumab pegol (CZP) 400 MG | 1件: Certolizumab pegol Certolizumab pegol (Certolizumab pegol) | 1件: Certolizumab pegol
Certolizumab pegol
(Certolizumab pegol, Certolizumab pegol) 💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 15 | Certolizumab pegol / cimzia | 1件: Certolizumab pegol Certolizumab pegol (Certolizumab pegol) | 1件: Certolizumab pegol
Certolizumab pegol
(Certolizumab pegol, Certolizumab pegol) 💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 💬
|
| 16 | Certolizumab pegol /cimzia | 1件: Certolizumab pegol Certolizumab pegol (Certolizumab pegol) | 1件: Certolizumab pegol
Certolizumab pegol
(Certolizumab pegol, Certolizumab pegol) 💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 17 | Certolizumab pegol 400 MG | 1件: Certolizumab pegol Certolizumab pegol (Certolizumab pegol) | 1件: Certolizumab pegol
Certolizumab pegol
(Certolizumab pegol, Certolizumab pegol) 💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 18 | Certoluzimab pegol | - | - | - | - | 1件: 46 46 💬
|
| 19 | Cimzia certolizumab pegol 200 MG/ML solution FOR injection | 1件: Certolizumab pegol Certolizumab pegol (Certolizumab pegol) | 1件: Certolizumab pegol
Certolizumab pegol
(Certolizumab pegol, Certolizumab pegol) 💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 💬
|
| 20 | D-A-tocopheryl PEG 1000 succinate | - | - | - | - | 1件: 299 299 💬
|
| 21 | Dapirolizumab pegol | 1件: Dapirolizumab pegol Dapirolizumab pegol (Dapirolizumab pegol) | - | - | - | 2件: 13 13, 49 💬
|
| 22 | Glatiramer acetate, interferons (intramuscular, subcutaneous, pegylated) teriflunomide, fumarates (dimethyl, diroximel, monomethyl) fingolimod, siponimod, ozanimod, ponesimod | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 23 | Hematide, peginesatide | 1件: Peginesatide Peginesatide (Peginesatide acetate) | 2件: Peginesatide
Peginesatide
(Peginesatide),
Peginesatide acetate
(Peginesatide acetate) 💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 283 283 💬
|
| 24 | Infliximab, adalimumab, certolizumab pegol | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 25 | Interferon beta 1A pegilado | 2件: Human interferon beta Human interferon beta, Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 26 | InterferóN beta 1A pegilado | - | - | - | - | 1件: 13 13 💬
|
| 27 | InterferóN BETA-1A pegilado | - | - | - | - | 1件: 13 13 💬
|
| 28 | IVIG-PEG | - | - | - | - | 1件: 65 65 💬
|
| 29 | Lulizumab pegol | 1件: Lulizumab pegol Lulizumab pegol (Lulizumab pegol) | - | - | - | 1件: 49 49 💬
|
| 30 | NON-pegylated interferon | - | - | - | - | 1件: 13 13 💬
|
| 31 | PEG | - | - | - | - | 8件: 6 6, 13, 41, 46, 76, 97, 246, 337 💬
|
| 32 | PEG LOW volume with bisacodyl | - | - | - | - | 1件: 97 97 💬
|
| 33 | PEG tube | - | - | - | - | 1件: 6 6 💬
|
| 34 | PEG-ADA | - | - | - | - | 1件: 65 65 💬
|
| 35 | PEG-interferon ALFA-2B | - | - | - | - | 1件: 26 26 💬
|
| 36 | PEG-interferon alpha-2B | - | - | - | - | 1件: 34 34 💬
|
| 37 | PEG-interleukin-2 | 1件: PEG-interleukin-2 PEG-interleukin-2 (PEG-interleukin-2) | - | - | - | 1件: 65 65 💬
|
| 38 | PEG-liposomal prednisolone sodium phosphate | 2件: Phosphate ion Phosphate ion, Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 97 💬
|
| 39 | PEG-RHG-CSF | - | - | - | - | 1件: 60 60 💬
|
| 40 | Pegcetacoplam | - | - | - | - | 1件: 2 2 💬
|
| 41 | Pegcetacoplan | 1件: Pegcetacoplan Pegcetacoplan (Pegcetacoplan) | 1件: Pegcetacoplan
Pegcetacoplan
(Pegcetacoplan) 💬
| 1件: C3 C3 💬
| 17件: Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | 4件: 2 2, 61, 62, 222 💬
|
| 42 | Pegfilgrastim | 1件: Pegfilgrastim Pegfilgrastim (peg-filgrastim) | 1件: Pegfilgrastim
Pegfilgrastim
(Pegfilgrastim, Pegfilgrastim, Pegfilgrastim, Pegfilgrastim-cbqv, Pegfilgrastim-bmez, Pegfilgrastim-fpgk) 💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 60 60 💬
|
| 43 | Peginesatide | 1件: Peginesatide Peginesatide (Peginesatide acetate) | 2件: Peginesatide
Peginesatide
(Peginesatide),
Peginesatide acetate
(Peginesatide acetate) 💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 283 283 💬
|
| 44 | Peginterferon ALFA-2A 180 MCG/ML injectable solution | 1件: Peginterferon alfa-2a Peginterferon alfa-2a (Pegylated interferon alpha-2a) | 1件: Peginterferon alfa-2a
Peginterferon alfa-2a
(Peginterferon alfa-2a, Peginterferon alfa-2a, Pegasys, PEGASYS) 💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 222 222 💬
|
| 45 | Peginterferon BETA-1A | 1件: Peginterferon beta-1a Peginterferon beta-1a (PEG IFN-beta-1a) | 1件: Peginterferon beta-1a
Peginterferon beta-1a
(Peginterferon beta-1a) 💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 46 | Peginterferone beta 1A | - | - | - | - | 1件: 13 13 💬
|
| 47 | Peginterferone BETA-1A | - | - | - | - | 1件: 13 13 💬
|
| 48 | Peginterferone lambda-1A | - | - | - | - | 1件: 13 13 💬
|
| 49 | Pegsunercept | 1件: Pegsunercept Pegsunercept (Pegsunercept) | 1件: Pegsunercept
Pegsunercept
(Pegsunercept) 💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 50 | Pegtarviliase IV | 1件: Pegtarviliase Pegtarviliase (Pegtarviliase) | - | - | - | 1件: 337 337 💬
|
| 51 | Pegtarviliase SC | 1件: Pegtarviliase Pegtarviliase (Pegtarviliase) | - | - | - | 1件: 337 337 💬
|
| 52 | Pegtibatinase | 1件: Pegtibatinase Pegtibatinase (Pegtibatinase) | 1件: Pegtibatinase
Pegtibatinase
(Pegtibatinase) 💬
| 1件: CBS CBS 💬
| 3件: Cysteine and methionine metabolism Cysteine and methionine metabolism, Glycine, serine and threonine metabolism, One carbon pool by folate 💬 | 1件: 337 337 💬
|
| 53 | Pegunigalsidase alfa | 1件: Pegunigalsidase alfa Pegunigalsidase alfa (Pegunigalsidase alfa) | 1件: Pegunigalsidase alfa
Pegunigalsidase alfa
(Pegunigalsidase alfa, Pegunigalsidase alfa-iwxj) 💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
| 54 | Pegunigalsidase alpha | - | - | - | - | 1件: 19 19 💬
|
| 55 | Pegunigalsidase-alfa | - | - | - | - | 1件: 19 19 💬
|
| 56 | Pegvaliase | 1件: Pegvaliase Pegvaliase (PEG-PAL) | 1件: Pegvaliase
Pegvaliase
(Pegvaliase, Pegvaliase, Pegvaliase-pqpz) 💬
| 1件: phhA phhA 💬
| 3件: Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
| 57 | Pegvaliase-pqpz | 1件: Pegvaliase Pegvaliase (PEG-PAL) | 1件: Pegvaliase
Pegvaliase
(Pegvaliase, Pegvaliase, Pegvaliase-pqpz) 💬
| 1件: phhA phhA 💬
| 3件: Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
| 58 | Pegvisomant | 1件: Pegvisomant Pegvisomant (Pegvisomant) | 1件: Pegvisomant
Pegvisomant
(Pegvisomant, Pegvisomant) 💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 2件: 77 77, 265 💬
|
| 59 | Pegvisomant treatment | 1件: Pegvisomant Pegvisomant (Pegvisomant) | 1件: Pegvisomant
Pegvisomant
(Pegvisomant, Pegvisomant) 💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 77 77 💬
|
| 60 | Pegvisomant/ sandostatin LAR | 1件: Pegvisomant Pegvisomant (Pegvisomant) | 1件: Pegvisomant
Pegvisomant
(Pegvisomant, Pegvisomant) 💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 77 77 💬
|
| 61 | Pegylated intereron BETA-1A | - | - | - | - | 1件: 13 13 💬
|
| 62 | Pegylated interferon alfa | - | - | - | - | 1件: 96 96 💬
|
| 63 | Pegylated interferon alpha2B | - | - | - | - | 1件: 227 227 💬
|
| 64 | Pegylated interferon BETA-1A | 2件: Human interferon beta Human interferon beta, Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 65 | Pegylated recombinant human hyaluronidase PH20 | 2件: Hyaluronidase (human recombinant) Hyaluronidase (human recombinant), Pegvorhyaluronidase alfa (Pegvorhyaluronidase alfa) | 2件: Hyaluronidase
Hyaluronidase
,
Pegvorhyaluronidase alfa
(Pegvorhyaluronidase alfa) 💬
| - | - | 1件: 28 28 💬
|
| 66 | Percutaneous endoscopic gastrostomy with A jejunal (PEG-J) tube | - | - | - | - | 1件: 6 6 💬
|
| 67 | Pharmacokinetics OF certolizumab pegol | - | - | - | - | 2件: 46 46, 96 💬
|
| 68 | Plegridy (peginterferon BETA-1A), biogen idec LTD | 1件: Peginterferon beta-1a Peginterferon beta-1a (PEG IFN-beta-1a) | 1件: Peginterferon beta-1a
Peginterferon beta-1a
(Peginterferon beta-1a) 💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 69 | Polyethylene glycol (PEG) | 1件: Polyethylene glycol Polyethylene glycol | 3件: Polyethylene glycol 3350
Polyethylene glycol 3350
(PEG),
Macrogol 4000
,
Macrogol 6000
💬
| - | - | 4件: 50 50, 97, 195, 299 💬
|
| 70 | Polyethylene glycol 3350 (PEG) | 1件: Polyethylene glycol Polyethylene glycol | 3件: Polyethylene glycol 3350
Polyethylene glycol 3350
(PEG),
Macrogol 4000
,
Macrogol 6000
💬
| - | - | 2件: 96 96, 299 💬
|
| 71 | Polyethylene glycol preparation (PEG) | 1件: Polyethylene glycol Polyethylene glycol | 3件: Polyethylene glycol 3350
Polyethylene glycol 3350
(PEG),
Macrogol 4000
,
Macrogol 6000
💬
| - | - | 1件: 96 96 💬
|
| 72 | Ravpal-PEG | 1件: Pegvaliase Pegvaliase (PEG-PAL) | 1件: Pegvaliase
Pegvaliase
(Pegvaliase, Pegvaliase, Pegvaliase-pqpz) 💬
| 1件: phhA phhA 💬
| 3件: Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
| 73 | Ravpal-PEG 0.001 MG/KG | 1件: Pegvaliase Pegvaliase (PEG-PAL) | 1件: Pegvaliase
Pegvaliase
(Pegvaliase, Pegvaliase, Pegvaliase-pqpz) 💬
| 1件: phhA phhA 💬
| 3件: Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
| 74 | Ravpal-PEG 0.003 MG/KG | 1件: Pegvaliase Pegvaliase (PEG-PAL) | 1件: Pegvaliase
Pegvaliase
(Pegvaliase, Pegvaliase, Pegvaliase-pqpz) 💬
| 1件: phhA phhA 💬
| 3件: Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
| 75 | Ravpal-PEG 0.01 MG/KG | 1件: Pegvaliase Pegvaliase (PEG-PAL) | 1件: Pegvaliase
Pegvaliase
(Pegvaliase, Pegvaliase, Pegvaliase-pqpz) 💬
| 1件: phhA phhA 💬
| 3件: Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
| 76 | Ravpal-PEG 0.03 MG/KG | 1件: Pegvaliase Pegvaliase (PEG-PAL) | 1件: Pegvaliase
Pegvaliase
(Pegvaliase, Pegvaliase, Pegvaliase-pqpz) 💬
| 1件: phhA phhA 💬
| 3件: Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
| 77 | Ravpal-PEG 0.1 MG/KG | 1件: Pegvaliase Pegvaliase (PEG-PAL) | 1件: Pegvaliase
Pegvaliase
(Pegvaliase, Pegvaliase, Pegvaliase-pqpz) 💬
| 1件: phhA phhA 💬
| 3件: Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
| 78 | Rondoraptivon pegol | 1件: BT200 BT200 (Rondoraptivon pegol) | - | - | - | 1件: 288 288 💬
|
| 79 | Rurioctocog alfa pegol | 1件: Rurioctocog alfa pegol Rurioctocog alfa pegol (Rurioctocog alfa pegol) | 1件: Rurioctocog alfa pegol
Rurioctocog alfa pegol
(Rurioctocog alfa pegol) 💬
| 1件: F8 F8 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 💬
|
| 80 | SC peginterferon BETA-1A | - | - | - | - | 1件: 13 13 💬
|
| 81 | Sodium phosphate enema, oral rifaximin and polyethylene glycol (PEG) | - | - | - | - | 1件: 6 6 💬
|